Global Information
회사소개 | 문의 | 비교리스트

간염 검사 키트 : 의료기기 파이프라인 평가

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 12월 상품 코드 640292
페이지 정보 영문 279 Pages
가격
US $ 4,000 ₩ 4,834,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,668,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 14,503,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


간염 검사 키트 : 의료기기 파이프라인 평가 Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 12월 페이지 정보 : 영문 279 Pages

세계 간염 검사 키트(Hepatitis Test Kits) 시장의 주요 파이프라인 제품과 임상시험 진행 상황에 대해 조사했으며, 제품의 기능·특성 비교 분석(임상시험 진행 단계별), 주요 기업 및 조직 개요와 대표적 제품, 최근의 시장 동향(실적 보고·자본 거래 동향 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 간염 검사 키트 개요

제3장 임상시험중인 제품

  • 파이프라인 제품 : 임상 단계별
  • 파이프라인 제품 : 분야별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별

제4장 간염 검사 키트 : 임상시험중인 파이프라인 제품, 기업별

  • 간염 검사 키트 기업 : 임상시험 단계별 파이프라인 제품
  • 간염 검사 키트 : 임상시험 단계별 파이프라인 제품

제5장 간염 검사 키트 시장 : 기업 및 제품 개요

  • Abbott Diagnostics
    • 파이프라인 제품 정보, 현재 진행중인 임상시험 개요
  • Alderon Biosciences Inc
  • AutoGenomics Inc
  • AXO Science SAS
  • Beckman Coulter Inc
  • Biokit SA
  • Biomagnetics Diagnostics Corp
  • Bio-Rad Laboratories Inc
  • Boditech Med Inc
  • CeMines, Inc.(Inactive)
  • Cepheid Company
  • China Medical Technologies Inc(Inactive)
  • Co-Diagnostics Inc
  • Corgenix Medical Corp
  • Da An Gene Co Ltd
  • Diagnostics for the Real World(Europe) Ltd
  • DiaSorin SpA
  • D-Kimia, LLC.
  • DNAE Group Holdings Ltd
  • Ecoli sro
  • Ferrer inCode SL
  • Fujirebio Diagnostics Inc
  • Genome Diagnostics Pvt. Ltd.
  • HealthTell Inc
  • Hepron Molecular Lab Inc
  • Hologic Inc
  • Imperial College London
  • LifeAssay Diagnostics(Pty)
  • MedMira Inc
  • Medosome Biotec LLC
  • Monogram Biosciences Inc
  • NanoDiagX
  • Ortho-Clinical Diagnostics Inc
  • Paramedical Srl
  • ProteinLogic Ltd
  • Qiagen NV
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Roche Diagnostics International Ltd
  • Sansure Biotech Inc
  • Seegene Inc
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Siemens Healthcare Diagnostics Inc
  • Siemens Healthineers AG
  • Stanford University
  • Syamala Srinivasa Life Sciences Pvt. Ltd
  • Sysmex Corp
  • TBG Diagnostics Ltd
  • University Medical Center Hamburg-Eppendorf
  • University of British Columbia
  • University of Texas Medical Branch at Galveston
  • University of Warwick
  • Ustar Biotechnologies(Hangzhou) Ltd.
  • Xiamen Zeesan Biotech Co.,Ltd

제6장 간염 검사 키트 시장 : 최근의 동향(총 10건)

제7장 부록

KSM 19.12.04

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Hepatitis Test Kits - Pipeline Products by Stage of Development 17
  • Table 2: Hepatitis Test Kits - Pipeline Products by Segment 18
  • Table 3: Hepatitis Test Kits - Pipeline Products by Territory 19
  • Table 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path 20
  • Table 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 21
  • Table 6: Hepatitis Test Kits Companies - Pipeline Products by Stage of Development 22
  • Table 7: Hepatitis Test Kits - Pipeline Products by Stage of Development 24
  • Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 9: Alinity i Assay - HCV Ag - Product Status 28
  • Table 10: Alinity i Assay - HCV Ag - Product Description 28
  • Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status 30
  • Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description 30
  • Table 13: ARCHITECT c4000 System - HbSAg Assay - Product Status 30
  • Table 14: ARCHITECT c4000 System - HbSAg Assay - Product Description 30
  • Table 15: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status 31
  • Table 16: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description 31
  • Table 17: Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 18: eSystem - Qualitative HCV RNA Assay - Product Status 32
  • Table 19: eSystem - Qualitative HCV RNA Assay - Product Description 32
  • Table 20: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 21: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status 33
  • Table 22: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description 33
  • Table 23: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status 35
  • Table 24: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description 35
  • Table 25: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 26: Multiplexed Detection - Anti-HCV Antibodies - Product Status 36
  • Table 27: Multiplexed Detection - Anti-HCV Antibodies - Product Description 36
  • Table 28: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 29: UniCel DxN - HCV Viral Load Test - Product Status 37
  • Table 30: UniCel DxN - HCV Viral Load Test - Product Description 37
  • Table 31: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 32: BIO-FLASH anti-HBe Assay - Product Status 38
  • Table 33: BIO-FLASH anti-HBe Assay - Product Description 38
  • Table 34: BIO-FLASH HAV Assay - Product Status 40
  • Table 35: BIO-FLASH HAV Assay - Product Description 40
  • Table 36: BIO-FLASH HBe Ag Assay - Product Status 40
  • Table 37: BIO-FLASH HBe Ag Assay - Product Description 41
  • Table 38: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 39: Diagnostic Test - Hepatitis B - Product Status 42
  • Table 40: Diagnostic Test - Hepatitis B - Product Description 42
  • Table 41: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 42: BioPlex 2200 - Hepatitis Test - Product Status 43
  • Table 43: BioPlex 2200 - Hepatitis Test - Product Description 43
  • Table 44: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 45: AFIAS-6 - Anti-HBs Test - Product Status 45
  • Table 46: AFIAS-6 - Anti-HBs Test - Product Description 45
  • Table 47: AFIAS-6 - HBsAg Test - Product Status 46
  • Table 48: AFIAS-6 - HBsAg Test - Product Description 46
  • Table 49: ichroma Test - Anti-HBs - Product Status 46
  • Table 50: ichroma Test - Anti-HBs - Product Description 46
  • Table 51: ichroma Test - HBsAg - Product Status 47
  • Table 52: ichroma Test - HBsAg - Product Description 47
  • Table 53: ichroma Test - HCV - Product Status 47
  • Table 54: ichroma Test - HCV - Product Description 47
  • Table 55: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 56: Diagnostic Test - Hepatitis C - Product Status 49
  • Table 57: Diagnostic Test - Hepatitis C - Product Description 49
  • Table 58: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 59: Xpert HCV Quant Assay - Product Status 50
  • Table 60: Xpert HCV Quant Assay - Product Description 50
  • Table 61: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 62: Diagnostic Assay - HCVA - Product Status 51

List of Figures

  • Figure 1: Hepatitis Test Kits - Pipeline Products by Stage of Development 15
  • Figure 2: Hepatitis Test Kits - Pipeline Products by Segment 16
  • Figure 3: Hepatitis Test Kits - Pipeline Products by Territory 17
  • Figure 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path 18
  • Figure 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 19

GlobalData's Medical Devices sector report, "Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Test Kits currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Test Kits pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hepatitis Test Kits under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Test Kits and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Test Kits under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 8
  • 1.2 List of Figures 13

2 Introduction 14

  • 2.1 Hepatitis Test Kits Overview 14

3 Products under Development 15

  • 3.1 Hepatitis Test Kits - Pipeline Products by Stage of Development 15
  • 3.2 Hepatitis Test Kits - Pipeline Products by Segment 16
  • 3.3 Hepatitis Test Kits - Pipeline Products by Territory 17
  • 3.4 Hepatitis Test Kits - Pipeline Products by Regulatory Path 18
  • 3.5 Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 19

4 Hepatitis Test Kits - Pipeline Products under Development by Companies 20

  • 4.1 Hepatitis Test Kits Companies - Pipeline Products by Stage of Development 20
  • 4.2 Hepatitis Test Kits - Pipeline Products by Stage of Development 22

5 Hepatitis Test Kits Companies and Product Overview 26

  • 5.1 Abbott Diagnostics Company Overview 26
    • 5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.2 Alderon Biosciences Inc Company Overview 29
    • 5.2.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.3 AutoGenomics Inc Company Overview 30
    • 5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.4 AXO Science SAS Company Overview 32
    • 5.4.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.5 Beckman Coulter Inc Company Overview 33
    • 5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.6 Biokit SA Company Overview 34
    • 5.6.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.7 Biomagnetics Diagnostics Corp Company Overview 37
    • 5.7.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.8 Bio-Rad Laboratories Inc Company Overview 38
    • 5.8.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.9 Boditech Med Inc Company Overview 39
    • 5.9.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.10 CeMines, Inc. (Inactive) Company Overview 42
    • 5.10.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.11 Cepheid Company Overview 43
    • 5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.12 China Medical Technologies Inc (Inactive) Company Overview 44
    • 5.12.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.13 Co-Diagnostics Inc Company Overview 45
    • 5.13.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.14 Corgenix Medical Corp Company Overview 46
    • 5.14.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.15 Da An Gene Co Ltd Company Overview 47
    • 5.15.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.16 Diagnostics for the Real World (Europe) Ltd Company Overview 50
    • 5.16.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.17 DiaSorin SpA Company Overview 51
    • 5.17.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.18 D-Kimia, LLC. Company Overview 54
    • 5.18.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.19 DNAE Group Holdings Ltd Company Overview 55
    • 5.19.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.20 Ecoli sro Company Overview 56
    • 5.20.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.21 Ferrer inCode SL Company Overview 59
    • 5.21.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.22 Fujirebio Diagnostics Inc Company Overview 60
    • 5.22.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.23 Genome Diagnostics Pvt. Ltd. Company Overview 68
    • 5.23.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.24 HealthTell Inc Company Overview 69
    • 5.24.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.25 Hepron Molecular Lab Inc Company Overview 71
    • 5.25.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.26 Hologic Inc Company Overview 72
    • 5.26.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.27 Imperial College London Company Overview 73
    • 5.27.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.28 LifeAssay Diagnostics (Pty) Ltd Company Overview 74
    • 5.28.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.29 MedMira Inc Company Overview 76
    • 5.29.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.30 Medosome Biotec LLC Company Overview 77
    • 5.30.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.31 Monogram Biosciences Inc Company Overview 78
    • 5.31.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.32 NanoDiagX Company Overview 79
    • 5.32.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.33 Ortho-Clinical Diagnostics Inc Company Overview 80
    • 5.33.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.34 Paramedical Srl Company Overview 85
    • 5.34.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.35 ProteinLogic Ltd Company Overview 91
    • 5.35.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.36 Qiagen NV Company Overview 92
    • 5.36.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.37 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 94
    • 5.37.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.38 Roche Diagnostics International Ltd Company Overview 95
    • 5.38.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.39 Sansure Biotech Inc Company Overview 103
    • 5.39.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 103
  • 5.40 Seegene Inc Company Overview 106
    • 5.40.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 106
  • 5.41 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 109
    • 5.41.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109
  • 5.42 Siemens Healthcare Diagnostics Inc Company Overview 111
    • 5.42.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 111
  • 5.43 Siemens Healthineers AG Company Overview 114
    • 5.43.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 114
  • 5.44 Stanford University Company Overview 118
    • 5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 118
  • 5.45 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 119
    • 5.45.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 119
  • 5.46 Sysmex Corp Company Overview 121
    • 5.46.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 121
  • 5.47 TBG Diagnostics Ltd Company Overview 123
    • 5.47.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 123
  • 5.48 University Medical Center Hamburg-Eppendorf Company Overview 125
    • 5.48.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview 125
  • 5.49 University of British Columbia Company Overview 126
    • 5.49.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 126
  • 5.50 University of Texas Medical Branch at Galveston Company Overview 127
    • 5.50.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 127
  • 5.51 University of Warwick Company Overview 128
    • 5.51.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 128
  • 5.52 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 129
    • 5.52.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
  • 5.53 Xiamen Zeesan Biotech Co.,Ltd Company Overview 130
    • 5.53.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

6 Hepatitis Test Kits- Recent Developments 131

  • 6.1 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 131
  • 6.2 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin 133
  • 6.3 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 133
  • 6.4 Nov 06, 2019: OraSure announces 2019 third quarter financial results 134
  • 6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 136
  • 6.6 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 138
  • 6.7 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 139
  • 6.8 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 141
  • 6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 142
  • 6.10 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 143

7 Appendix 276

  • 7.1 Methodology 276
  • 7.2 About GlobalData 279
  • 7.3 Contact Us 279
  • 7.4 Disclaimer 279
Back to Top
전화 문의
F A Q